삼성서울병원

Ko En

소화기내과 신동현 교수

진료분야
간암, 간경화, 급성간염, 만성간염, 지방간, 간이식, 간질환
진료일정 03 月
날짜
01
02
03
04
05
06
07
08
09
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
오전
오후
진료일정 04 月
날짜
01
02
03
04
05
06
07
08
09
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
오전
오후
" 내과와 외과를 아우르는 다학제 접근으로
간질환 영역의 최고를 꿈꾸다 "

소화기내과 신동현 교수는 다학제적 접근으로 간암, 간질환 및 간부전 환자들을 진료하고 있습니다. 다양한 모습으로 나타나는 간암, 간질환, 간부전 환자들에게 개인 맞춤형 최선의 치료가 무엇인지, 간암의 일차 및 이차 예방은 어떻게 해야 하는지, 간 이식 전후 최적화된 관리 방법은 무엇인지 연구하고 있습니다.

SMC 블로그 바로가기

학력

학력
2013.08 성균관대학교 의과대학 의학과 의학박사
2006.02 성균과대학교 의과대학 의학과 의학석사
2001.02 단국대학교 의과대학 의학사

경력

경력
2016.03 ~현재 성균관대학교 삼성서울병원 소화기내과 부교수
2014.0301 ~ 2016.02 성균관대학교 삼성서울병원 소화기내과 전임대우 임상조교수
2012.0301 ~ 2014.02 인제대학교 상계백병원 소화기내과 조교수
2011.0501 ~ 2012.02 성균관대학교 삼성서울병원 소화기내과 연구강사
2009.03 ~ 2011.04 국군수도병원 소화기내과 군의관
2008.05 ~ 2009.02 국군대전병원 내과 군의관
2006.0301 ~ 2008.02 성균관대학교 삼성서울병원 소화기내과 임상강사
2002.0301 ~ 2006.02 성균관대학교 삼성서울병원 내과 레지던트
2001.0301 ~ 2002.02 성균관대학교 삼성서울병원 인턴

학회활동

학회활동
2015.11 ~ 현재 대한간학회 간행위원
2013.07 ~ 현재 대한간암학회 간행 위원
2014.03 ~ 2015.10 대한간학회 홍보위원
2013.07 ~ 2015.06 대한간암학회 학술 위원
  • HPB 2021 10.1016/j.hpb.2020.10.011 Comparison of ICC patients with hepatitis B infection to those with no major risk factors for HCC Kim1, KM; Na, JE; Shim, SG; Sinn, DH
    View PubMed
  • J CLIN APHERESIS 2021 10.1002/jca.21873 Initial experience with high-volume plasma exchange in patients with acute liver failure Kim1, JE; Chun, S; Sinn, DH; Kim, NJ; Kim, S; Kang, W; Kim, JM; Choi, GS; Joh, JW; Cho, D
    View PubMed
  • HEPATOLOGY 2021 10.1002/hep.31567 REPLY Goh1, MJ; Sinn, DH; Woo, SY; Kim, S
    View PubMed
  • ANN SURG 2021 10.1097/SLA.0000000000003268 Effect of Microvascular Invasion Risk on Early Recurrence of Hepatocellular Carcinoma After Surgery and Radiofrequency Ablation Lee1, S; Kang, TW; Song, KD; Lee, MW; Rhim, H; Lim, HK; Kim, SY; Sinn, DH; Kim, JM; Kim, K; Ha, SY
    View PubMed
  • PLOS ONE 2021 10.1371/journal.pone.0246143 Survival in untreated hepatocellular carcinoma: A national cohort study Kim1, YA; Kang, D; Moon, H; Sinn, D; Kang, M; Woo, SM; Chang, YJ; Park, B; Kong, SY; Guallar, E; Shin, SY; Gwak, G; Back, JH; Lee, ES; Cho, J
    View PubMed
  • EUR J RADIOL 2021 10.1016/j.ejrad.2020.109474 Gadoxetic acid-enhanced MRI for differentiating hepatic sclerosing hemangioma from malignant tumor Kim1, YY; Kang, TW; Cha, DI; Min, JH; Kim, YK; Kim, SH; Sinn, DH; Won, H; Kim, S
    View PubMed
  • AM J GASTROENTEROL 2021 10.14309/ajg.0000000000000966 Alcohol Intake and Mortality in Patients With Chronic Viral Hepatitis: A Nationwide Cohort Study Sinn1, DH; Kang, D; Guallar, E; Chang, Y; Ryu, S; Zhao, D; Hong, YS; Cho, J; Gwak, GY
    View PubMed
  • DIGEST LIVER DIS 2021 10.1016/j.dld.2020.10.030 A comparison of factors associated with the temporal improvement in the overall survival of BCLC stage 0 hepatocellular carcinoma patients Song1, BG; Kim, MJ; Sinn, DH; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY 2021 10.14309/ctg.0000000000000290 Risk and Risk Score Performance of Hepatocellular Carcinoma Development in Patients With Hepatitis B Surface Antigen Seroclearance Park1, Y; Lee, JH; Sinn, DH; Park, JY; Kim, MA; Kim, YJ; Yoon, JH; Kim, DY; Ahn, SH; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • LIVER CANCER 2021 10.1159/000512239 Efficacy and Safety of Lenvatinib Therapy for Unresectable Hepatocellular Carcinoma in a Real-World Practice in Korea Goh1, MJ; Oh, JH; Park, Y; Kim, J; Kang, W; Sinn, DH; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • RADIOLOGY 2021 10.1148/radiol.2020200885 Comparison of Super-Resolution US and Contrast Material-enhanced US in Detection of the Spoke Wheel Sign in Patients with Focal Nodular Hyperplasia Kang1, TW; Jeong, WK; Kim, YY; Min, JH; Kim, YK; Kim, SH; Sinn, DH; Kim, K
    View PubMed
  • DIGEST DIS SCI 2021 10.1007/s10620-020-06134-4 Patterns and Outcomes in Hepatocellular Carcinoma Patients with Portal Vein Invasion: A Multicenter Prospective Cohort Study Sinn1, DH; Lee, HW; Paik, YH; Kim, DY; Kim, YJ; Kim, KM; Bae, SH; Kim, JH; Seo, YS; Jang, JY; Jang, BK; Yim, HJ; Kim, HJ; Lee, BS; Kim, BH; Kim, IH; Cho, EY; Lee, JI; Suh, KS
    View PubMed
  • YONSEI MED J 2021 10.3349/ymj.2021.62.1.12 Prognostic Value of Alpha-Fetoprotein in Patients Who Achieve a Complete Response to Transarterial Chemoembolization for Hepatocellular Carcinoma Lee1, JS; Chon, YE; Kim, BK; Park, JY; Kim, DY; Ahn, SH; Han, KH; Kang, W; Choi, MS; Gwak, GY; Paik, YH; Lee, JH; Koh, KC; Paik, SW; Kim, HY; Kim, TH; Yoo, K; Ha, Y; Kim, MN; Lee, JH; Hwang, SG; Kim, SS; Cho, HJ; Cheong, JY; Cho, SW; Park, SH; Heo, NY; Hong, YM; Yoon, KT; Cho, M; Park, JG; Kang, MK; Park, SY; Kweon, YO; Tak, WY; Jang, SY; Sinn, DH; Kim, SU
    View PubMed
  • GUT 2020 10.1136/gutjnl-2019-320015 Discontinuation of nucleos(t)ide analogues is not associated with a higher risk of HBsAg seroreversion after antiviral-induced HBsAg seroclearance a nationwide multicentre study Kim1, MA; Kim, SU; Sinn, DH; Jang, JW; Lim, YS; Ahn, SH; Shim, JJ; Seo, YS; Baek, YH; Kim, SG; Kim, YS; Kim, JH; Choe, WH; Yim, HJ; Lee, HW; Kwon, JH; Lee, SW; Jang, JY; Kim, HY; Park, Y; Kim, GA; Yang, H; Lee, HA; Koh, M; Lee, YS; Kim, M; Chang, Y; Kim, YJ; Yoon, JH; Zoulim, F; Lee, JH
    View PubMed
  • SCAND J GASTROENTERO 2020 10.1080/00365521.2020.1866063 Prognosis of hepatocellular carcinoma patients diagnosed under regular surveillance potential implications for surveillance goal Song1, JH; Goh, MJ; Park, Y; Oh, JH; Kang, W; Sinn, DH; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • J DIABETES INVEST 2020 10.1111/jdi.13455 Mean and visit-to-visit variability of glycated hemoglobin, and the risk of non-alcoholic fatty liver disease Yoo1, JH; Kang, M; Kim, G; Hur, KY; Kim, JH; Sinn, DH; Jin, SM
    View PubMed
  • EUR RADIOL 2020 10.1007/s00330-020-07438-9 Vanishing washout of hepatocellular carcinoma according to the presence of hepatic steatosis diagnostic performance of CT and MRI Min1, JH; Kang, TW; Kim, YY; Cha, DI; Kim, YK; Kim, SH; Sinn, DH; Ha, SY; Kim, K
    View PubMed
  • ANN SURG TREAT RES 2020 10.4174/astr.2020.99.4.238 Comparison of outcome between liver resection, radiofrequency ablation, and transarterial therapy for multiple small hepatocellular carcinoma within the Milan criteria Oh1, JH; Sinn, DH; Choi, GS; Kim, JM; Joh, JW; Kang, TW; Hyun, D; Kang, W; Gwak, GY; Paik, YH; Lee, JH; Koh, KC; Paik, SW; Choi, MS
    View PubMed
  • CLIN MOL HEPATOL 2020 10.3350/cmh.2020.0016 Substantial risk of recurrence even after 5 recurrence-free years in early-stage hepatocellular carcinoma patients Kim1, J; Kang, W; Sinn, DH; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • INT J EPIDEMIOL 2020 10.1093/ije/dyaa089 Risk of hepatocellular carcinoma in individuals without traditional risk factors development and validation of a novel risk score Sinn1, DH; Kang, D; Cho, SJ; Paik, SW; Guallar, E; Cho, J; Gwak, GY
    View PubMed
  • CANCERS 2020 10.3390/cancers12102791 Novel Model to Predict HCC Recurrence after Liver Transplantation Obtained Using Deep Learning A Multicenter Study Nam1, JY; Lee, JH; Bae, J; Chang, Y; Cho, Y; Sinn, DH; Kim, BH; Kim, SH; Yi, NJ; Lee, KW; Kim, JM; Park, JW; Kim, YJ; Yoon, JH; Joh, JW; Suh, KS
    View PubMed
  • CANCER RES TREAT 2020 10.4143/crt.2020.208 Evaluation of the American Joint Committee on Cancer (AJCC) 8th Edition Staging System for Hepatocellular Carcinoma in 1,008 Patients with Curative Resection Park1, S; Choi, S; Cho, YA; Sinn, DH; Kim, JM; Park, CK; Ha, SY
    View PubMed
  • CLIN MOL HEPATOL 2020 10.3350/cmh.2020.0049 Comparison of clinical practice guidelines for the management of chronic hepatitis B When to start, when to change, and when to stop Yim1, HJ; Kim, JH; Park, JY; Yoon, EL; Park, H; Kwon, JH; Sinn, DH; Lee, SH; Lee, JH; Lee, HW
    View PubMed
  • DIGEST DIS SCI 2020 10.1007/s10620-020-06591-x Different Performance of Liver Stiffness Measurement According to Etiology and Outcome for the Prediction of Liver-Related Events Oh1, JH; Goh, MJ; Park, Y; Kim, J; Kang, W; Sinn, DH; Gwak, GY; Choi, MS; Lee, JH; Koh, KC; Paik, SW; Paik, YH
    View PubMed
  • KOREAN J RADIOL 2020 10.3348/kjr.2019.0910 Effect of Perfluorobutane Microbubbles on Radiofrequency Ablation for Hepatocellular Carcinoma Suppression of Steam Popping and Its Clinical Implication Jeong1, DY; Kang, TW; Min, JH; Song, KD; Lee, MW; Rhim, H; Lim, HK; Sinn, DH; Han, H
    View PubMed
  • SCAND J GASTROENTERO 2020 10.1080/00365521.2020.1788139 Child-Pugh, MELD, MELD-Na, and ALBI scores which liver function models best predicts prognosis for HCC patient with ascites? Kim1, KM; Shim, SG; Sinn, DH; Song, JE; Kim, BS; Kim, HG
    View PubMed
  • DIGEST DIS SCI 2020 10.1007/s10620-020-06533-7 Direct-Acting Antivirals Improve Treatment Outcomes in Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma Treated with Transarterial Chemoembolization A Nationwide, Multi-center, Retrospective Cohort Study Hyun1, HK; Cho, EJ; Park, SY; Hong, YM; Kim, SS; Kim, HY; Heo, NY; Park, JG; Sinn, DH; Kang, W; Jeong, SW; Song, MJ; Park, H; Lee, D; Lee, YS; Cho, SB; An, CS; Rhee, HJ; Lee, HW; Kim, BK; Park, JY; Kim, D; Ahn, SH; Han, KH; Lee, JH; Yu, SJ; Kim, YJ; Yoon, JH; Tak, WY; Kweon, YO; Yoon, KT; Cho, M; Cheong, JY; Park, SH; Kim, SU
    View PubMed
  • CLIN MOL HEPATOL 2020 10.3350/cmh.2020.0084 Low-level viremia in patients undergoing antiviral therapy Does it indicate time for a change? Kim1, JH; Sinn, DH
    View PubMed
  • ALIMENT PHARM THER 2020 10.1111/apt.15741 Extremely low risk of hepatocellular carcinoma development in patients with chronic hepatitis B in immune-tolerant phase Lee1, HA; Lee, HW; Kim, IH; Park, SY; Sinn, DH; Yu, JH; Seo, YS; Um, SH; Lee, JI; Lee, KS; Lee, CH; Tak, WY; Kweon, YO; Kang, W; Paik, YH; Lee, JW; Suh, SJ; Jung, YK; Kim, BK; Park, JY; Kim, Y; Ahn, SH; Han, KH; Yim, HJ; Kim, SU
    View PubMed
  • J VIRAL HEPATITIS 2020 10.1111/jvh.13279 Hepatitis B reactivation after kidney transplantation in hepatitis B surface antigen-negative, core antibody-positive recipients Kim1, J; Chung, SJ; Sinn, DH; Lee, KW; Park, JB; Huh, W; Lee, JE; Jang, HR; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • BMC CANCER 2020 10.1186/s12885-020-06975-2 A differential risk assessment and decision model for Transarterial chemoembolization in hepatocellular carcinoma based on hepatic function Nam1, JY; Choe, AR; Sinn, DH; Lee, JH; Kim, HY; Yu, SJ; Kim, YJ; Yoon, JH; Lee, JM; Chung, JW; Choi, SY; Lee, JK; Baek, SY; Lee, HA; Kim, TH; Yoo, K
    View PubMed
  • EXP CLIN TRANSPLANT 2020 10.6002/ect.2018.0071 Infectious Complications in Patients Who Received High-Volume Plasma Exchange Prior to Liver Transplant: A Case Report Park1, GE; Peck, KR; Kim, JM; Kwon, CHD; Joh, JW; Cho, D; Sinn, DH
    View PubMed
  • HEPATOLOGY 2020 10.1002/hep.31079 Letter to the Editor: Statins and Reduced Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B REPLY Goh1, MJ; Kim, S; Woo, SY; Sinn, DH
    View PubMed
  • RADIOLOGY 2020 10.1148/radiol.2020190639 Use of Gadoxetic Acid enhanced Liver MRI and Morality in More than 30000 Patients with Hepatocellular Carcinoma: A Nationwide Analysis Kang1, TW; Kong, SY; Kang, D; Kang, MW; Kim, YK; Kim, SH; Sinn, DH; Kim, YA; Choi, KS; Lee, ES; Cho, J; Guallar, E; Back, JH; Woo, SM
    View PubMed
  • TRANSPL P 2020 10.1016/j.transproceed.2020.01.037 Changes in Tumor Markers and Their Implications in Selecting Liver Transplantation for Patients With Hepatocellular Carcinoma Song1, BG; Sinn, DH; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW; Kim, JM; Joh, JW; Choi, GS
    View PubMed
  • J VIRAL HEPATITIS 2020 10.1111/jvh.13304 Incidence of extrahepatic cancers among individuals with chronic hepatitis B or C virus infection: A nationwide cohort study Hong1, CY; Sinn, DH; Kang, D; Paik, SW; Guallar, E; Cho, J; Gwak, GY
    View PubMed
  • EUR RADIOL 2020 10.1007/s00330-019-06575-0 Updated 10-year outcomes of percutaneous radiofrequency ablation as first-line therapy for single hepatocellular carcinoma < 3 cm: emphasis on association of local tumor progression and overall survival Lee1, MW; Kang, D; Lim, HK; Cho, J; Sinn, DH; Kang, TW; Song, KD; Rhim, H; Cha, DI; Lu, DSK
    View PubMed
  • JMIR mHealth and uHealth 2020 10.2196/14435 Efficacy and Safety of an mHealth App and Wearable Device in Physical Performance for Patients With Hepatocellular Carcinoma: Development and Usability Study Kim1, Y; Seo, J; An, SY; Sinn, DH; Hwang, JH
    View PubMed
  • CARDIOVASC INTER RAD 2020 10.1007/s00270-019-02394-4 RF Ablation Versus Cryoablation for Small Perivascular Hepatocellular Carcinoma: Propensity Score Analyses of Mid-Term Outcomes Cha1, SY; Kang, TW; Min, JH; Song, KD; Lee, MW; Rhim, H; Lim, HK; Sinn, DH; Park, MS
    View PubMed
  • J CLIN ENDOCR METAB 2020 10.1210/clinem/dgz040 Weight Change and Development of Subclinical Carotid Atherosclerosis Among Metabolically Healthy Adults: A Cohort Study Sinn1, DH; Kang, D; Cho, SJ; Chang, Y; Ryu, S; Bin Song, Y; Paik, SW; Hong, YS; Zhao, D; Guallar, E; Cho, J; Gwak, GY
    View PubMed
  • EUR RADIOL 2020 10.1007/s00330-019-06407-1 Deep learning with ultrasonography: automated classification of liver fibrosis using a deep convolutional neural network Lee1, JH; Joo, I; Kang, TW; Paik, YH; Sinn, DH; Ha, SY; Kim, K; Choi, C; Lee, GW; Yi, JH; Bang, WC
    View PubMed
  • J GASTROINTEST SURG 2020 10.1007/s11605-020-04540-7 Incidence of and Risk Factors for Alcohol Relapse After Liver Transplantation for Alcoholic Liver Disease: Comparison Between Deceased Donor and Living Donor Liver Transplantation Chung1, HG; Sinn, DH; Kang, W; Choi, GS; Kim, JM; Joh, JW
    View PubMed
  • KOREAN JOURNAL OF INTERNAL MEDICINE 2020 10.3904/kjim.2018.196 Real world data on follicular lymphoma patients treated by rituximab-containing immunochemotherapy and rituximab maintenance Kim1, HK; Kang, W; Sinn, DH; Lee, JH; Kim, WS; Kim, SJ
    View PubMed
  • KOREAN JOURNAL OF INTERNAL MEDICINE 2020 10.3904/kjim.2018.040 Potential etiology, prevalence of cirrhosis, and mode of detection among patients with non-B non-C hepatocellular carcinoma in Korea Kim1, J; Kang, W; Sinn, DH; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • J GASTROEN HEPATOL 2019 10.1111/jgh.14750 Hepatitis B virus DNA levels and overall survival in hepatitis B-related hepatocellular carcinoma patients with low-level viremia Kim1, TS; Sinn, DH; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • CANCERS 2019 10.3390/cancers11111721 Tumor Marker-Based Definition of the Transarterial Chemoembolization-Refractoriness in Intermediate-Stage Hepatocellular Carcinoma: A Multi-Cohort Study Yoon1, JS; Sinn, DH; Lee, JH; Kim, HY; Lee, CH; Kim, SW; Lee, HY; Nam, JY; Chang, Y; Lee, YB; Cho, EJ; Yu, SJ; Kim, HC; Chung, JW; Kim, YJ; Yoon, JH
    View PubMed
  • J CLIN MED 2019 10.3390/jcm8101600 The Impact of Previous Acute Decompensation on the Long-Term Prognosis of Alcoholic Hepatitis in Cirrhotic Patients Yoon1, EL; Kim, TY; Song, D; Kim, HY; Kim, CW; Jung, YK; Sinn, DH; Jang, JY; Kim, MY; Jeong, SW; Kim, SG; Suk, KT; Kim, DJ; Han, BH; Lee, BS; Lee, CH; Chae, HB; Kwon, HC; Lee, HJ; Kim, HS; Cho, HC; Yim, HJ; Kim, JH; Suh, JI; Yang, JM; Sohn, JH; Lee, SS; Nam, SW; Park, SH; Baik, SK; Kim, SE; Kim, TH; Choe, WH; Kim, YS
    View PubMed
  • CANCERS 2019 10.3390/cancers11091295 Comparison of Models for Tumor Recurrence after Liver Transplantation for the Patients with Hepatocellular Carcinoma: A Multicenter Long-Term Follow-Up Study Chang1, Y; Cho, Y; Lee, JH; Lee, YB; Cho, EJ; Yu, SJ; Sinn, DH; Kim, BH; Kim, SH; Yi, NJ; Lee, KW; Kim, JM; Park, JW; Kim, YJ; Yoon, JH; Joh, JW; Suh, KS
    View PubMed
  • J GASTROEN HEPATOL 2019 10.1111/jgh.14856 Non-alcoholic fatty liver disease and the incidence of myocardial infarction: A cohort study Sinn1, DH; Kang, D; Chang, Y; Ryu, S; Cho, SJ; Paik, SW; Song, YB; Pastor-Barriuso, R; Guallar, E; Cho, J; Gwak, GY
    View PubMed
  • J GASTROINTEST SURG 2019 10.1007/s11605-018-04074-z Nomograms in Hepatectomy Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma Kim1, JM; Kwon, CHD; Joh, JW; Yoo, H; Kim, K; Sinn, DH; Choi, GS; Lee, JH
    View PubMed
  • EUR J ENDOCRINOL 2019 10.1530/EJE-19-0143 Lean non-alcoholic fatty liver disease and development of diabetes: a cohort study Sinn1, DH; Kang, D; Choi, SJ; Paik, SW; Guallar, E; Cho, J; Gwak, GY
    View PubMed
  • J VIRAL HEPATITIS 2019 10.1111/jvh.13185 The risk of hepatocellular carcinoma among chronic hepatitis B virus-infected patients outside current treatment criteria Sinn1, DH; Kim, SE; Kim, BK; Kim, JH; Choi, MS
    View PubMed
  • BMC CANCER 2019 10.1186/s12885-019-5740-z Adjuvant cytokine-induced killer cell immunotherapy for hepatocellular carcinoma: a propensity score-matched analysis of real-world data Yoon1, JS; Song, BG; Lee, JH; Lee, HY; Kim, SW; Chang, Y; Lee, YB; Cho, EJ; Yu, SJ; Sinn, DH; Kim, YJ; Lee, JH; Yoon, JH
    View PubMed
  • EUR RADIOL 2019 10.1007/s00330-018-5868-2 Radiofrequency ablation for subcardiac hepatocellular carcinoma: therapeutic outcomes and risk factors for technical failure Cha1, DI; Kang, TW; Song, KD; Lee, MW; Rhim, H; Lim, HK; Sinn, DH; Kim, K
    View PubMed
  • BMC CANCER 2019 10.1186/s12885-019-5508-5 Late presentation of hepatitis B among patients with newly diagnosed hepatocellular carcinoma: a national cohort study Sinn1, DH; Kang, D; Kang, M; Paik, SW; Guallar, E; Cho, J; Gwak, GY
    View PubMed
  • PLoS One 2019 10.1371/journal.pone.0213547 Hepatocellular carcinoma with extrahepatic metastasis: Are there still candidates for transarterial chemoembolization as an initial treatment? Kim1, J; Sinn, DH; Choi, MS; Kang, W; Gwak, GY; Paik, YH; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • KOREAN J RADIOL 2019 10.3348/kjr.2018.0339 Identification of Arterial Hyperenhancement in CT and MRI in Patients with Hepatocellular Carcinoma: Value of Unenhanced Images Kim1, M; Kang, TW; Cha, DI; Jang, KM; Kim, YK; Kim, SH; Sinn, DH; Kim, K
    View PubMed
  • J CLIN GASTROENTEROL 2019 10.1097/MCG.0000000000000987 Long-term Prognosis of Acute-on-Chronic Liver Failure Survivors Yoon1, EL; Kim, TY; Lee, CH; Kim, TH; Cho, HC; Lee, SS; Kim, SE; Kim, HY; Kim, CW; Song, DS; Yang, JM; Sinn, DH; Jung, YK; Yim, HJ; Kim, HS; Sohn, JH; Kim, JH; Choe, WH; Lee, BS; Kim, MY; Jeong, SW; Choi, E; Kim, DJ
    View PubMed
  • EUR RADIOL 2019 10.1007/s00330-018-5617-6 Percutaneous cryoablation for perivascular hepatocellular carcinoma: Therapeutic efficacy and vascular complications Kim1, R; Kang, TW; Cha, DI; Song, KD; Lee, MW; Rhim, H; Lim, HK; Sinn, DH
    View PubMed
  • PLoS One 2019 10.1371/journal.pone.0210730 Multidisciplinary approach is associated with improved survival of hepatocellular carcinoma patients Sinn1, DH; Choi, GS; Park, HC; Kim, JM; Kim, H; Song, KD; Kang, TW; Lee, MW; Rhim, H; Hyun, D; Cho, SK; Shin, SW; Jeong, WK; Kim, SH; Il Yu, J; Ha, SY; Lee, SJ; Lim, HY; Kim, K; Ahn, JH; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Joh, JW; Lim, HK; Paik, SW
    View PubMed
  • EUR J GASTROEN HEPAT 2018 10.1097/MEG.0000000000001226 Additional role of liver stiffness measurement in stratifying residual hepatocellular carcinoma risk predicted by serum biomarkers in chronic hepatitis B patients under antiviral therapy Song1, BG; Sinn, DH; Chi, S; Kim, K; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • ANN SURG 2018 10.1097/SLA.0000000000002318 Risk of Post-transplant Hepatocellular Carcinoma Recurrence Is Higher in Recipients of Livers From Male Than Female Living Donors Han1, S; Yang, JD; Sinn, DH; Kim, JM; Choi, GS; Jung, G; Ahn, JH; Kim, S; Ko, JS; Gwak, MS; Kwon, CHD; Leise, MD; Gwak, GY; Heimbach, JK; Kim, GS
    View PubMed
  • J CLIN MICROBIOL 2018 10.1128/JCM.00438-18 Comparative Evaluation of QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold Plus in Diagnosis of Latent Tuberculosis Infection in Immunocompromised Patients Ryu1, MR; Park, MS; Cho, EH; Jung, CW; Kim, K; Kim, SJ; Oh, HY; Huh, W; Jang, HR; Koh, WJ; Park, HY; Kim, YH; Sinn, DH; Choi, JO; Joh, JW; Kim, JM; Kim, SJ; Park, JB; Kang, ES
    View PubMed
  • LIVER TRANSPLANT 2018 10.1002/lt.25307 Laparoscopic Donor Hepatectomy for Adult Living Donor Liver Transplantation Recipients Kwon1, CHD; Choi, GS; Kim, JM; Cho, CW; Rhu, J; Kim, GS; Sinn, DH; Joh, JW
    View PubMed
  • TRANSPLANTATION 2018 10.1097/TP.0000000000002154 ABO-incompatible Living Donor Liver Transplantation With Rituximab and Total Plasma Exchange Does Not Increase Hepatocellular Carcinoma Recurrence Kim1, JM; Kwon, CHD; Joh, JW; Han, S; Yoo, J; Kim, K; Sinn, DH; Choi, GS; Gerber, DA; Egawa, H; Lee, SK
    View PubMed
  • Abdom Radiol (NY) 2018 10.1007/s00261-018-1480-9 Adding ancillary features to enhancement patterns of hepatocellular carcinoma on gadoxetic acid-enhanced magnetic resonance imaging improves diagnostic performance Min1, JH; Kim, YK; Sinn, DH; Choi, SY; Jeong, WK; Lee, WJ; Ha, SY; Ahn, S; Kim, MJ
    View PubMed
  • RADIOLOGY 2018 10.1148/radiol.2018172743 Percutaneous US/MRI Fusion-guided Radiofrequency Ablation for Recurrent Subcentimeter Hepatocellular Carcinoma: Technical Feasibility and Therapeutic Outcomes Song1, KD; Lee, MW; Rhim, H; Kang, TW; Cha, DI; Sinn, DH; Lim, HK
    View PubMed
  • ANN SURG TREAT RES 2018 10.4174/astr.2018.95.3.147 Use of direct antiviral agents in liver transplant recipients with hepatitis C virus in Korea: 2-center experience Kim1, JM; Lee, KW; Sinn, DH; Choi, GS; Yi, NJ; Kwon, CHD; Suh, KS; Joh, JW
    View PubMed
  • LIVER INT 2018 10.1111/liv.13732 Validation of the Baveno VI and the expanded Baveno VI criteria to identify patients who could avoid screening endoscopy Bae1, J; Sinn, DH; Kang, W; Gwak, GY; Choi, MS; Paik, YH; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • J HEPATOL 2018 10.1016/j.jhep.2018.02.026 Radiofrequency ablation vs. surgery for perivascular hepatocellular carcinoma: Propensity score analyses of long-term outcomes Lee1, S; Kang, TW; Cha, DI; Song, KD; Lee, MW; Rhim, H; Lim, HK; Sinn, DH; Kim, JM; Kim, K
    View PubMed
  • CLIN RADIOL 2018 10.1016/j.crad.2018.02.007 Radiofrequency ablation versus surgical resection for multiple HCCs meeting the Milan criteria: propensity score analyses of 10-year therapeutic outcomes Min1, JH; Kang, TW; Cha, DI; Song, KD; Lee, MW; Rhim, H; Sinn, DH; Kim, JM; Sohn, I
    View PubMed
  • SCAND J GASTROENTERO 2018 10.1080/00365521.2018.1458895 Treatment for occult hepatocellular carcinoma: does it offer survival advantages over symptom-driven treatment? Kim1, KM; Kim, J; Sinn, DH; Kim, HS; Kim, K; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • J HEPATOL 2018 10.1016/j.jhep.2018.01.024 Hepatobiliary MRI as novel selection criteria in liver transplantation for hepatocellular carcinoma Kim1, AY; Sinn, DH; Jeong, WK; Kim, YK; Kang, TW; Ha, SY; Park, CK; Choi, GS; Kim, JM; Kwon, CHD; Joh, JW; Kim, MJ; Sohn, I; Jung, SH; Paik, SW; Lee, WJ
    View PubMed
  • J GASTROEN HEPATOL 2018 10.1111/jgh.14042 Non-alcoholic fatty liver disease and the development of reflux esophagitis: A cohort study Min1, YW; Kim, Y; Gwak, GY; Gu, S; Kang, D; Cho, SJ; Guallar, E; Cho, J; Sinn, DH
    View PubMed
  • SCI REP-UK 2018 10.1038/s41598-018-25628-w Sarcopenia as a predictor of post-transplant tumor recurrence after living donor liver transplantation for hepatocellular carcinoma beyond the Milan criteria Kim1, YR; Park, S; Han, S; Ahn, JH; Kim, S; Sinn, DH; Jeong, WK; Ko, JS; Gwak, MS; Kim, GS
    View PubMed
  • DIGEST DIS SCI 2018 10.1007/s10620-018-4934-6 Novel Albumin-Bilirubin Grade-Based Risk Prediction Model for Patients with Hepatocellular Carcinoma Undergoing Chemoembolization Kim1, JH; Sinn, DH; Lee, JH; Hyun, D; Cho, SK; Shin, SW; Chang, Y; Kim, YJ; Yoon, JH; Kang, W; Gwak, GY; Paik, YH; Lee, JH; Koh, KC; Paik, SW; Choi, MS
    View PubMed
  • J GASTROEN HEPATOL 2018 10.1111/jgh.13991 Validation of prognostic scores to predict short-term mortality in patients with acute-on-chronic liver failure Song1, DS; Kim, TY; Kim, DJ; Kim, HY; Sinn, DH; Yoon, EL; Kim, CW; Jung, YK; Suk, KT; Lee, SS; Lee, CH; Kim, TH; Choe, WH; Yim, HJ; Kim, SE; Baik, SK; Jang, JY; Kim, HS; Kim, SG; Yang, JM; Sohn, JH; Choi, EH; Cho, HC; Jeong, SW; Kim, MY
    View PubMed
  • ANN SURG TREAT RES 2018 10.4174/astr.2018.94.4.183 Prognosis of preoperative positron emission tomography uptake in hepatectomy patients Kim1, JM; Kwon, CHD; Joh, JW; Sinn, DH; Choi, GS; Paik, SW
    View PubMed
  • SCI REP-UK 2018 10.1038/s41598-018-23014-0 Nonalcoholic fatty liver disease accelerates kidney function decline in patients with chronic kidney disease: a cohort study Jang1, HR; Kang, D; Sinn, DH; Gu, S; Cho, SJ; Lee, JE; Huh, W; Paik, SW; Ryu, S; Chang, Y; Shafi, T; Lazo, M; Guallar, E; Cho, J; Gwak, GY
    View PubMed
  • CLIN IMAG 2018 10.1016/j.clinimag.2017.08.004 The qualitative and quantitative image analysis of MR imaging in patients with acute-on-chronic liver failure Kang1, TW; Kim, M; Kim, YK; Kim, SH; Sinn, DH; Kim, K
    View PubMed
  • LIVER INT 2018 10.1111/liv.13489 Non-invasive tests for liver disease severity and the hepatocellular carcinoma risk in chronic hepatitis B patients with low-level viremia Paik1, N; Sinn, DH; Lee, JH; Oh, IS; Kim, JH; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • J INFECT DIS 2017 10.1093/infdis/jix506 Nucleos(t)ide Analogue Treatment for Patients With Hepatitis B Virus (HBV) e Antigen-Positive Chronic HBV Genotype C Infection: A Nationwide, Multicenter, Retrospective Study Chang1, Y; Choe, WH; Sinn, DH; Lee, JH; Ahn, SH; Lee, H; Shim, JJ; Jun, DW; Park, SY; Nam, JY; Cho, EJ; Yu, SJ; Lee, DH; Lee, JM; Kim, YJ; Kwon, SY; Paik, SW; Yoon, JH
    View PubMed
  • J HEPATOL 2017 Development of chronic kidney disease in patients with non-alcoholic fatty liver disease: A cohort study Sinn1, DH; Kang, D; Jang, HR; Gu, S; Cho, SJ; Paik, SW; Ryu, S; Chang, Y; Lazo, M; Guallar, E; Cho, J; Gwak, GY
    View PubMed
  • J GASTROENTEROL 2017 10.1007/s00535-017-1337-y A cohort study on Helicobacter pylori infection associated with nonalcoholic fatty liver disease Kim1, TJ; Sinn, DH; Min, YW; Son, HJ; Kim, JJ; Chang, Y; Baek, SY; Ahn, SH; Lee, H; Ryu, S
    View PubMed
  • DIGEST DIS SCI 2017 10.1007/s10620-017-4775-8 Liver Function Assessment Using Albumin-Bilirubin Grade for Patients with Very Early-Stage Hepatocellular Carcinoma Treated with Radiofrequency Ablation Oh1, IS; Sinn, DH; Kang, TW; Lee, MW; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • SCI REP-UK 2017 10.1038/s41598-017-13501-1 Cell-surface major vault protein promotes cancer progression through harboring mesenchymal and intermediate circulating tumor cells in hepatocellular carcinomas Lee1, HM; Joh, JW; Seo, SR; Kim, WT; Kim, MK; Choi, HS; Kim, SY; Jang, YJ; Sinn, DH; Choi, GS; Kim, JM; Kwon, CHD; Chang, HJ; Kim, DS; Ryu, CJ
    View PubMed
  • J HEPATOL 2017 10.1016/j.jhep.2017.04.024 Preoperative gadoxetic acid-enhanced MRI for predicting microvascular invasion in patients with single hepatocellular carcinoma Lee1, S; Kim, SH; Lee, JE; Sinn, DH; Park, CK
    View PubMed
  • ONCOTARGET 2017 10.18632/oncotarget.17072 Combination treatment with transarterial chemoembolization, radiotherapy, and hyperthermia (CERT) for hepatocellular carcinoma with portal vein tumor thrombosis: Final results of a prospective phase II trial Yu1, JI; Park, HC; Jung, SH; Choi, C; Shin, SW; Cho, SK; Sinn, DH; Paik, YH; Gwak, GY; Choi, MS; Lee, JH; Koh, KC; Yoo, BC; Sahinbas, H; Paik, SW
    View PubMed
  • EUR RADIOL 2017 10.1007/s00330-016-4662-2 Gadoxetic acid-enhanced magnetic resonance imaging characteristics of hepatocellular carcinoma occurring in liver transplants Kim1, M; Kang, TW; Jeong, WK; Kim, YK; Kim, SH; Kim, JM; Sinn, DH; Kim, MJ; Jung, SH
    View PubMed
  • HEPATOLOGY 2017 10.1002/hep.28916 Low-Level Viremia and the Increased Risk of Hepatocellular Carcinoma in Patients Receiving Entecavir Treatment Kim1, JH; Sinn, DH; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • GUT LIVER 2017 10.5009/gnl16403 A Novel Model for Predicting Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B and Normal Alanine Aminotransferase Levels Sinn1, DH; Lee, JH; Kim, K; Ahn, JH; Lee, JH; Kim, JH; Lee, DH; Yoon, JH; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • KOREAN JOURNAL OF INTERNAL MEDICINE 2017 10.3904/kjim.2016.096 Long-term real-world entecavir therapy in treatment-naive hepatitis B patients: base-line hepatitis B virus DNA and hepatitis B surface antigen levels predict virologic response Cho1, JY; Sohn, W; Sinn, DH; Gwak, GY; Paik, YH; Choi, MS; Koh, KC; Paik, SW; Yoo, BC; Lee, JH
    View PubMed
  • J Gastroenterol Hepatol. 2017 May;32(5):1100-1106. doi: 10.1111/jgh.13647. Insulin resistance and the risk of hepatocellular carcinoma in chronic hepatitis B patients Kim JH11, Sinn DH1, Gwak GY1, Kang W1, Paik YH1, Choi MS1, Lee JH1, Koh KC1, Paik SW1.
    View PubMed
  • Gut. 2017 Feb;66(2):323-329. doi: 10.1136/gutjnl-2016-311854. Epub 2016 Sep 6. Non-alcoholic fatty liver disease and progression of coronary artery calcium score: a retrospective cohort study Sinn DH11, Kang D2, Chang Y3,4,5, Ryu S3,4,5, Gu S6, Kim H6, Seong D2, Cho SJ7, Yi BK2,8, Park HD9, Paik SW1, Song YB1,10, Lazo M10, Lima JA10, Guallar E10, Cho J2,3,5,10, Gwak GY1.
    View PubMed
  • Aliment Pharmacol Ther. 2017 Feb;45(4):577-578. doi: 10.1111/apt.13911. Letter: Helicobacter pylori-related non-alcoholic fatty liver disease with concomitant metabolic syndrome as risk factor for colorectal neoplasia - authors' reply Ahn JS11, Sinn DH1, Son HJ1,2, Gwak GY1.
    View PubMed
  • CLINICAL RADIOLOGY, FEB 2017, 72(2):141-149, DOI: 10.1016/j.crad.2016.09.008 Radiofrequency ablation and transarterial chemoembolisation as first-line treatment for recurrent hepatocellular carcinoma or isolated intrahepatic recurrent hepatocellular carcinoma Kim SS1, Kang TW, Song KD, Cho SK, Lee MW, Rhim H, Sinn DH, Jung SH
    View PubMed
  • Aliment Pharmacol Ther. 2017 Jan;45(2):345-353. doi: 10.1111/apt.13866. Epub 2016 Nov 18. Non-alcoholic fatty liver diseases and risk of colorectal neoplasia Ahn JS11, Sinn DH1, Min YW1, Hong SN1, Kim HS2, Jung SH2, Gu S3, Rhee PL1, Paik SW1, Son HJ4, Gwak GY1.
    View PubMed
  • Gut Liver. 2016 Nov 15;10(6):939-947. doi: 10.5009/gnl15527. Lamivudine versus Entecavir for Newly Diagnosed Hepatitis B Virus-Related Hepatocellular Carcinoma Kim JH11, Sinn DH1, Kim K2, Kim H2, Gwak GY1, Paik YH1, Choi MS1, Lee JH1, Koh KC1, Paik SW1.
    View PubMed
  • World J Gastroenterol. 2016 Nov 7;22(41):9205-9213. Assessment of scoring systems for acute-on-chronic liver failure at predicting short-term mortality in patients with alcoholic hepatitis Kim HY11, Kim CW1, Kim TY1, Song DS1, Sinn DH1, Yoon EL1, Jung YK1, Suk KT1, Lee SS1, Lee CH1, Kim TH1, Kim JH1, Yim HJ1, Kim SE1, Baik SK1, Lee BS1, Jang JY1, Kim YS1, Kim SG1, Yang JM1, Sohn JH1, Lee HJ1, Park SH1, Choi EH1, Kim DJ1; Korean Acute-on-Chronic Liver Failure Study Group.
    View PubMed
  • Dig Dis Sci. 2016 Nov;61(11):3354-3362. Epub 2016 Jul 19. Primary Prophylaxis for Variceal Bleeding and the Improved Survival of Patients with Newly Diagnosed Hepatocellular Carcinoma Kim JH11, Sinn DH2, Kim K3, Kang W1, Gwak GY1, Paik YH1, Choi MS1, Lee JH1, Koh KC1, Paik SW1.
    View PubMed
  • PLoS One. 2016 Nov 15;11(11):e0165722. doi: 10.1371/journal.pone.0165722. eCollection 2016. Survival Analysis of Single Large (> 5 cm) Hepatocellular Carcinoma Patients: BCLC A versus B Cho Y11,2, Sinn DH3, Yu SJ1, Gwak GY3, Kim JH4, Yoo YJ4, Jun DW5, Kim TY6, Lee HY5, Cho EJ1, Lee JH1, Kim YJ1, Yoon JH1.
    View PubMed
  • Liver Int. 2016 Oct;36(10):1490-7. doi: 10.1111/liv.13107. Epub 2016 Mar 24. The recommended treatment algorithms of the BCLC and HKLC staging systems: does following these always improve survival rates for HCC patients? Kim KM11, Sinn DH2, Jung SH3, Gwak GY2, Paik YH2, Choi MS2, Lee JH2, Koh KC2, Paik SW4.
    View PubMed
  • Gastroenterology. 2016 Sep;151(3):481-488.e1. doi: 10.1053/j.gastro.2016.06.001. Epub 2016 Jun 7. Persistent Nonalcoholic Fatty Liver Disease Increases Risk for Carotid Atherosclerosis Sinn DH11, Cho SJ2, Gu S3, Seong D4, Kang D5, Kim H6, Yi BK7, Paik SW1, Guallar E8, Cho J8, Gwak GY9.
    View PubMed
  • Gut Liver. 2016 Sep 15;10(5):796-802. doi: 10.5009/gnl15368. Prediction of the Risk of Hepatocellular Carcinoma in Chronic Hepatitis C Patients after Sustained Virological Response by Aspartate Aminotransferase to Platelet Ratio Index Lee K11, Sinn DH1, Gwak GY1, Cho HC2, Jung SH3, Paik YH1, Choi MS1, Lee JH1, Koh KC1, Paik SW1.
    View PubMed
  • Transplantation. 2016 Sep;100(9):1933-8. doi: 10.1097/TP.0000000000001293. Higher Bilirubin Levels of Healthy Living Liver Donors Are Associated With Lower Posttransplant Hepatocellular Carcinoma Recurrence Han S11, Yang JD, Sinn DH, Ko JS, Kim JM, Shin JC, Son HJ, Gwak MS, Joh JW, Kim GS.
    View PubMed
  • Ann Surg. 2016 Aug;264(2):339-43. doi: 10.1097/SLA.0000000000001486. Safety of the Use of Blood Salvage and Autotransfusion During Liver Transplantation for Hepatocellular Carcinoma Han S11, Kim G, Ko JS, Sinn DH, Yang JD, Joh JW, Lee SK, Gwak MS.
    View PubMed
  • Medicine (Baltimore). 2016 Aug;95(35):e4735. doi: 10.1097/MD.0000000000004735. Factors determining long-term outcomes of hepatocellular carcinoma within the Milan criteria: liver transplantation versus locoregional therapy: A retrospective cohort study Kim JH11, Sinn DH, Gwak GY, Choi GS, Kim JM, Kwon CH, Joh JW, Kim KY, Kim K, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW.
    View PubMed
  • Oncotarget. 2016 Jul 26;7(30):47794-47807. doi: 10.18632/oncotarget.10026. Effect of oral antiviral treatment on long-term outcomes of radiofrequency ablation therapy for hepatitis B virus-related hepatocellular carcinoma Sohn W11,2, Kang TW3, Choi SK4, Jung SH4, Lee MW3, Lim HK3,5, Cho JY1,6, Shim SG7, Sinn DH1, Gwak GY1, Choi MS1, Lee JH1, Koh KC1, Paik SW1, Rhim H3, Paik YH1,5.
    View PubMed
  • JOURNAL OF KOREAN MEDICAL SCIENCE, MAY 2016, 31(5):825-826, DOI: 10.3346/jkms.2016.31.5.825 Anti-Viral Therapy for Compensated Liver Cirrhosis Patients with Normal Alanine Aminotransferase Response Lee J1, Sinn DH, Paik SW
    View PubMed
  • Int J Hyperthermia. 2016 May;32(3):331-8. doi: 10.3109/02656736.2016.1144895. Epub 2016 Feb 25. Combination treatment of trans-arterial chemo-embolisation, radiotherapy and hyperthermia (CERT) for hepatocellular carcinoma with portal vein tumour thrombosis: Interim analysis of prospective phase II trial Yu JI11, Park HC1,2, Oh D1, Noh JM1, Jung SH1, Kim HY1, Shin SW3, Cho SK3, Sinn DH4, Paik YH4, Gwak GY4, Choi MS4, Lee JH4, Koh KC4, Paik SW4, Yoo BC5.
    View PubMed
  • Cardiovasc Intervent Radiol. 2016 Apr;39(4):620-3. doi: 10.1007/s00270-015-1222-0. Epub 2015 Oct 30. Portal Vein Stenting for Portal Biliopathy with Jaundice Hyun D11, Park KB2, Lim SJ3, Hwang JH4, Sinn DH5.
    View PubMed
  • World J Gastroenterol. 2016 Apr 14;22(14):3785-92. doi: 10.3748/wjg.v22.i14.3785. Characteristics and outcomes of chronic liver disease patients with acute deteriorated liver function by severity of underlying liver disease Hong YS11, Sinn DH1, Gwak GY1, Cho J1, Kang D1, Paik YH1, Choi MS1, Lee JH1, Koh KC1, Paik SW1.
    View PubMed
  • Gut Liver. 2016 Mar;10(2):295-302. doi: 10.5009/gnl15155. Relationship between Controlled Attenuation Parameter and Hepatic Steatosis as Assessed by Ultrasound in Alcoholic or Nonalcoholic Fatty Liver Disease Ahn JM11, Paik YH1, Min SY1, Cho JY1, Sohn W1, Sinn DH1, Gwak GY1, Choi MS1, Lee JH1, Koh KC1, Paik SW1, Yoo BC1.
    View PubMed
  • Br J Surg. 2016 Feb;103(3):276-83. doi: 10.1002/bjs.10048. Epub 2015 Dec 23. Case-matched comparison of ABO-incompatible and ABO-compatible living donor liver transplantation Kim JM11, Kwon CH1, Joh JW1, Han SB2, Sinn DH3, Choi GS1, Kang ES4, Lee JH3, Kim GS2, Lee SK1.
    View PubMed
  • Medicine (Baltimore). 2016 Feb;95(7):e2718. doi: 10.1097/MD.0000000000002718. Predicting Hepatic Steatosis in Living Liver Donors via Noninvasive Methods Kim JM11, Ha SY, Joh JW, Sinn DH, Jeong WK, Choi GS, Gwak GY, Kwon CH, Kim YK, Paik YH, Lee JH, Lee WJ, Lee SK, Park CK.
    View PubMed
  • Liver Transpl. 2016 Feb;22(2):209-16. doi: 10.1002/lt.24336. Conversion of once-daily extended-release tacrolimus is safe in stable liver transplant recipients: A randomized prospective study Kim JM11, Kwon CH1, Joh JW1, Sinn DH2, Lee S1, Choi GS1, Lee SK1.
    View PubMed
  • PLoS One. 2016 Jan 20;11(1):e0146745. doi: 10.1371/journal.pone.0146745. eCollection 2016. Characteristics and Discrepancies in Acute-on-Chronic Liver Failure: Need for a Unified Definition Kim TY11, Song do S2, Kim HY2, Sinn DH3, Yoon EL4, Kim CW2, Jung YK5, Suk KT6, Lee SS7, Lee CH8, Kim TH9, Kim JH10, Choe WH10, Yim HJ5, Kim SE11, Baik SK12, Lee BS13, Jang JY14, Suh J 3rd15, Kim HS16, Nam SW17, Kwon HC17, Kim YS18, Kim SG18, Chae HB19, Yang JM2, Sohn JH20, Lee HJ21, Park SH22, Han BH23, Choi EH24, Kim CH25, Kim DJ6; Korean Acute-on-Chronic Liver Failure Study Group.
  • Medicine (Baltimore). 2016 Jan;95(3):e2578. doi: 10.1097/MD.0000000000002578. Nonalcoholic Fatty Liver Disease for Identification of Preclinical Carotid Atherosclerosis Sinn DH11, Cho SJ, Gwak GY, Cho J, Gu S, Seong D, Kang D, Kim H, Yi BK, Paik SW.
    View PubMed
  • PLoS One. 2015 Dec 22;10(12):e0144777. doi: 10.1371/journal.pone.0144777. eCollection 2015. Prediction of Clinical Outcomes in Hepatitis B E Antigen Negative Chronic Hepatitis B Patients with Elevated Hepatitis B Virus DNA Levels Ahn JM11,2, Sinn DH1, Gwak GY1, Paik YH1, Choi MS1, Lee JH1, Koh KC1, Paik SW1.
    View PubMed
  • Dig Dis Sci. 2015 Dec;60(12):3794-800. doi: 10.1007/s10620-015-3812-8. Epub 2015 Jul 28. Stopping Preemptive Antiviral Therapy for Hepatitis B Virus Can Be Considered for Patients with Favorable Predictors Kim HJ11, Sinn DH2, Kim NJ1, Kim JH1, Kim E1, Gwak GY1, Paik YH1, Choi MS1, Lee JH1, Koh KC1, Paik SW1, Yoo BC1.
    View PubMed
  • J Korean Med Sci. 2015 Nov;30(11):1618-24. doi: 10.3346/jkms.2015.30.11.1618. Epub 2015 Oct 16. Hepatocellular Carcinoma Risk of Compensated Cirrhosis Patients with Elevated HBV DNA Levels according to Serum Aminotransferase Levels Lee J11, Sinn DH1, Kim JH1, Gwak GY1, Kim HS2, Jung SH2, Paik YH1, Choi MS1, Lee JH1, Koh KC1, Yoo BC1, Paik SW1.
    View PubMed
  • Liver Int. 2015 Nov;35(11):2363-9. doi: 10.1111/liv.12838. Epub 2015 Apr 12. Hepatitis B reactivation in multiple myeloma patients with resolved hepatitis B undergoing chemotherapy Lee JY11, Lim SH1, Lee MY1, Kim H1, Sinn DH1, Gwak GY1, Choi MS1, Lee JH1, Jung CW1, Jang JH1, Kim WS1, Kim SJ1, Kim K1.
    View PubMed
  • Medicine (Baltimore). 2015 Nov;94(44):e1771. doi: 10.1097/MD.0000000000001771. Early Enteral Feeding After Living Donor Liver Transplantation Prevents Infectious Complications A Prospective Pilot Study Kim JM11, Joh JW, Kim HJ, Kim SH, Rha M, Sinn DH, Choi GS, Kwon CH, Cho YY, Suh JM, Lee SK.
    View PubMed
  • Hepatology. 2015 Sep;62(3):694-701. doi: 10.1002/hep.27889. Epub 2015 Jul 3. Hepatocellular carcinoma risk in chronic hepatitis B virus-infected compensated cirrhosis patients with low viral load Sinn DH11, Lee J1, Goo J2, Kim K2, Gwak GY1, Paik YH1, Choi MS1, Lee JH1, Koh KC1, Yoo BC1, Paik SW1.
    View PubMed
  • J Viral Hepat. 2015 Jun;22(6):539-50. doi: 10.1111/jvh.12356. Epub 2014 Nov 7. Influence of hepatitis B virus reactivation on the recurrence of HBV-related hepatocellular carcinoma after curative resection in patients with low viral load Sohn W11, Paik YH, Cho JY, Ahn JM, Choi GS, Kim JM, Kwon CH, Joh JW, Sinn DH, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC.
    View PubMed
  • J Hepatol. 2015 May;62(5):1112-21. doi: 10.1016/j.jhep.2014.12.009. Epub 2014 Dec 13. Sorafenib therapy for hepatocellular carcinoma with extrahepatic spread: Treatment outcome and prognostic factors Sohn W11, Paik YH2, Cho JY1, Lim HY1, Ahn JM1, Sinn DH1, Gwak GY1, Choi MS1, Lee JH1, Koh KC1, Paik SW1, Yoo BC1.
    View PubMed
  • PLoS One. 2015 May 5;10(5):e0123554. doi: 10.1371/journal.pone.0123554. eCollection 2015. Oral Valganciclovir as a Preemptive Treatment for Cytomegalovirus (CMV) Infection in CMV-Seropositive Liver Transplant Recipients Kim JM11, Kwon CH1, Joh JW1, Ha YE2, Sinn DH3, Choi GS1, Peck KR2, Lee SK1.
    View PubMed
  • PLoS One. 2015 Apr 29;10(4):e0124434. doi: 10.1371/journal.pone.0124434. eCollection 2015. Different Survival of Barcelona Clinic Liver Cancer Stage C Hepatocellular Carcinoma Patients by the Extent of Portal Vein Invasion and the Type of Extrahepatic Spread Sinn DH11, Cho JY1, Gwak GY1, Paik YH1, Choi MS1, Lee JH1, Koh KC1, Paik SW1, Yoo BC1.
    View PubMed
  • World J Gastroenterol. 2015 Mar 28;21(12):3587-92. doi: 10.3748/wjg.v21.i12.3587. Appropriate empirical antibiotic use and 30-d mortality in cirrhotic patients with bacteremia Park H11, Jang KJ1, Jang W1, Park SH1, Park JY1, Jeon TJ1, Oh TH1, Shin WC1, Choi WC1, Sinn DH1.
    View PubMed
  • Digestion. 2015;91(2):150-7. doi: 10.1159/000369789. Epub 2015 Feb 11. Association between Serum Osteocalcin Levels and Non-Alcoholic Fatty Liver Disease in Women Sinn DH11, Gwak GY, Rhee SY, Cho J, Son HJ, Paik YH, Choi MS, Lee JH, Koh KC, Yoo BC, Paik SW.
    View PubMed
  • Hepatogastroenterology. 2015 Mar-Apr;62(138):286-90. Synchronous and Metachronous Colorectal Cancers: Distinct Disease Entities or Different Disease Courses Huang CS1, Yang SH, Lin CC, Lan YT, Chang SC, Wang HS, Chen WS, Lin TC, Lin JK, Jiang JK.
    View PubMed
  • Medicine (Baltimore). 2015 Feb;94(6):e450. doi: 10.1097/MD.0000000000000450. Incidental Microscopic Bile Duct Tumor Thrombi in Hepatocellular Carcinoma after Curative Hepatectomy A Matched Study Kim JM11, Kwon CH, Joh JW, Sinn DH, Park JB, Lee JH, Kim SJ, Paik SW, Park CK, Yoo BC.
    View PubMed
  • PLoS One. 2014 Nov 5;9(11):e112184. doi: 10.1371/journal.pone.0112184. eCollection 2014. Comparison of Clinical Manifestations and Outcomes between Hepatitis B Virus- and Hepatitis C Virus-Related Hepatocellular Carcinoma: Analysis of a Nationwide Cohort Sinn DH11, Gwak GY1, Cho J2, Paik SW1, Yoo BC1.
    View PubMed
  • Dig Liver Dis. 2014 Sep;46(9):813-7. doi: 10.1016/j.dld.2014.05.003. Epub 2014 Jun 2. A prediction model for liver abscess developing after transarterial chemoembolization in patients with hepatocellular carcinoma Shin JU11, Kim KM2, Shin SW3, Min SY4, Park SU4, Sinn DH4, Gwak GY4, Choi MS4, Lee JH4, Paik SW4, Yoo BC4, Koh KC5.
    View PubMed
  • Atherosclerosis. 2014 Jun;234(2):270-5. doi: 10.1016/j.atherosclerosis.2014.03.001. Epub 2014 Mar 21. Modest alcohol consumption and carotid plaques or carotid artery stenosis in men with non-alcoholic fatty liver disease Sinn DH11, Gwak GY2, Cho J3, Son HJ4, Paik YH5, Choi MS5, Lee JH5, Koh KC5, Paik SW5, Yoo BC5.
    View PubMed
  • Transplantation. 2013 Jun 15;95(11):1404-9. doi: 10.1097/TP.0b013e31828d1588. Steatosis Among Living Liver Donors Without Evidence of Fatty Liver on Ultrasonography: Potential Implications for Preoperative Liver Biopsy Ahn JS11, Sinn DH, Gwak GY, Kim JM, Kwon CH, Joh JW, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC.
    View PubMed
  • J Gastroenterol Hepatol. 2010 Mar;25(3):539-43. doi: 10.1111/j.1440-1746.2009.06108.x. Change in cross-sectional area of esophageal muscle does not correlate with the outcome of achalasia after pneumatic balloon dilatation Sinn DH11, Choi YS, Kim JH, Kim ER, Son HJ, Kim JJ, Rhee JC, Rhee PL.
    View PubMed
  • Hepatogastroenterology.?2009 May-Jun;56(91-92):672-6. Effectiveness of Each Bethesda Marker in Defining Microsatellite Instability when Screening for Lynch Syndrome Sinn DH11,?Chang DK,?Kim YH,?Rhee PL,?Kim JJ,?Kim DS,?Park CK,?Kim JW,?Yun SH,?Lee WY,?Chun HK,?Rhee JC.
    View PubMed
  • Liver Int. 2008 Dec;28(10):1363-9. doi: 10.1111/j.1478-3231.2008.01860.x. Disease progression and the risk factor analysis for chronic hepatitis C Sinn DH11, Paik SW, Kang P, Kil JS, Park SU, Lee SY, Song SM, Gwak GY, Choi MS, Lee JH, Koh KC, Yoo BC.
    View PubMed
  • Dig Dis Sci.?2008 Oct;53(10):2714-8. doi: 10.1007/s10620-007-0196-4. Epub 2008 Feb 15. Therapeutic effect of Lactobacillus acidophilus-SDC 2012, 2013 in patients with irritable bowel syndrome Sinn DH11,?Song JH,?Kim HJ,?Lee JH,?Son HJ,?Chang DK,?Kim YH,?Kim JJ,?Rhee JC,?Rhee PL.
    View PubMed
  • Aliment Pharmacol Ther.?2008 Jun;27(12):1275-81. doi: 10.1111/j.1365-2036.2008.03659.x. Epub 2008 Feb 27. Response rate and predictors of response in a short-term empirical trial of high-dose rabeprazole in patients with globus Sinn DH11,?Kim JH,?Kim S,?Son HJ,?Kim JJ,?Rhee JC,?Rhee PL.
    View PubMed